nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19
|
Backer, Vibeke |
|
|
4 |
C |
p. |
artikel |
2 |
Confronting the burden of tobacco-related lung cancer in Europe in the next decades
|
ten Haaf, Kevin |
|
|
4 |
C |
p. |
artikel |
3 |
Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak
|
Kardas, Przemyslaw |
|
|
4 |
C |
p. |
artikel |
4 |
Do asymptomatic carriers of SARS-COV-2 transmit the virus?
|
Muller, Claude P. |
|
|
4 |
C |
p. |
artikel |
5 |
Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study
|
Yegorov, Sergey |
|
|
4 |
C |
p. |
artikel |
6 |
Excess mortality for men and women above age 70 according to level of care during the first wave of COVID-19 pandemic in Sweden: A population-based study
|
Modig, K. |
|
|
4 |
C |
p. |
artikel |
7 |
Getting hands on a drug for Covid-19: Inhaled and Intranasal Niclosamide
|
Kunzelmann, Karl |
|
|
4 |
C |
p. |
artikel |
8 |
How digital transformation can help achieve value-based healthcare: Balkans as a case in point
|
Rosalia, Rodney Alexander |
|
|
4 |
C |
p. |
artikel |
9 |
Impact of tobacco control policies implementation on future lung cancer incidence in Europe: An international, population-based modeling study
|
Gredner, Thomas |
|
|
4 |
C |
p. |
artikel |
10 |
Maximising public adherence to COVID-19 self-isolation in Europe
|
Patel, Jay |
|
|
4 |
C |
p. |
artikel |
11 |
Mortality trends among hospitalised COVID-19 patients in Sweden: A nationwide observational cohort study
|
Strålin, Kristoffer |
|
|
4 |
C |
p. |
artikel |
12 |
Predictors of self-reported adherence to COVID-19 guidelines. A longitudinal observational study of 51,600 UK adults
|
Wright, Liam |
|
|
4 |
C |
p. |
artikel |
13 |
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults
|
Ward, Helen |
|
|
4 |
C |
p. |
artikel |
14 |
Prevalence of mental disorders, suicidal ideation and suicides in the general population before and during the COVID-19 pandemic in Norway: A population-based repeated cross-sectional analysis
|
Knudsen, Ann Kristin Skrindo |
|
|
4 |
C |
p. |
artikel |
15 |
Prisons need to be included in global and national vaccinations effort against COVID-19
|
Neufeld, Maria |
|
|
4 |
C |
p. |
artikel |
16 |
Reply to "How the EU vaccine troubles could have partially been prevented ten years ago"
|
Senninger, Roman |
|
|
4 |
C |
p. |
artikel |
17 |
SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg
|
Wilmes, Paul |
|
|
4 |
C |
p. |
artikel |
18 |
Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study
|
Rawshani, Aidin |
|
|
4 |
C |
p. |
artikel |
19 |
Sociodemographic factors and uncomplicated cystitis in women aged 15–50 years: a nationwide Swedish cohort registry study (1997–2018)
|
Jansåker, Filip |
|
|
4 |
C |
p. |
artikel |
20 |
Socioeconomic deprivation and cancer survival in a metropolitan area: An analysis of cancer registry data from Hamburg, Germany
|
Jansen, Lina |
|
|
4 |
C |
p. |
artikel |
21 |
Suicide in England in the COVID-19 pandemic: Early observational data from real time surveillance
|
Appleby, Louis |
|
|
4 |
C |
p. |
artikel |
22 |
Waning antibodies to SARS-CoV-2 – Don't panic
|
Meyer, Benjamin |
|
|
4 |
C |
p. |
artikel |
23 |
World No Tobacco Day 2021: will Europe commit to quit?
|
|
|
|
4 |
C |
p. |
artikel |